BREANNA JAMES: Open Payments
NPI 1164043667 · MIDDLEBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,396 in 61 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $66 · 2025 $1,396
Food & beverage: $1,396
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $262 |
| ABBVIE INC. | 10 | $208 |
| AstraZeneca Pharmaceuticals LP | 6 | $147 |
| Astellas Pharma US Inc | 4 | $88 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $78 |
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $73 |
| GlaxoSmithKline, LLC. | 3 | $61 |
| Medtronic, Inc. | 1 | $50 |
| Novo Nordisk Inc | 3 | $50 |
Products named: MOUNJARO, JARDIANCE, VRAYLAR, Veozah, CAPLYTA, FARXIGA, UBRELVY, REXULTI.
Industry payments across FL — which companies pay providers there.
